Nocebo effects in practice: methotrexate myths and misconceptions

This publication has 19 references indexed in Scilit:

• A decade of Australian methotrexate dosing errors
  Medical Journal of Australia, 2016
• 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
  Arthritis Care & Research, 2015
• Safety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditions
  Seminars in Arthritis and Rheumatism, 2015
• Unhelpful information about adverse drug reactions
  BMJ, 2014
• Medicine's inconvenient truth: the placebo and nocebo effect
  Internal Medicine Journal, 2014
• Folic Acid and Folinic Acid for Reducing Side Effects in Patients Receiving Methotrexate for Rheumatoid Arthritis
  The Journal of Rheumatology, 2014
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
  Annals of the Rheumatic Diseases, 2014
• Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs
  The Journal of Rheumatology, 2011
• Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis
  Pharmacological Reviews, 2005
• Effects of methotrexate esters and other lipophilic antifolates on methotrexate-resistant human leukemic lymphoblasts
  Biochemical Pharmacology, 1980